Isoniazid Preventive Therapy, Hepatitis C Virus Infection, and Hepatotoxicity among Injection Drug Users Infected withMycobacterium tuberculosis
Open Access
- 15 November 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1687-1691
Abstract
Treatment of latent Mycobacterium tuberculosis infection with isoniazid can cause hepatotoxicity, but the risk of isoniazid-associated hepatotoxicityKeywords
This publication has 30 references indexed in Scilit:
- Isoniazid Toxicity in Health Care WorkersClinical Infectious Diseases, 1999
- A Prospective, Community–Based Evaluation of Liver Enzymes in Individuals With Hepatitis C After Drug UseHepatology, 1999
- Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial diseaseArchives of internal medicine (1960), 1996
- The influence of intravenous drug use and HIV infection in the transmission of tuberculosisAIDS, 1996
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995
- Sociodemographic predictors and temporal trends of extrapulmonary tuberculosis as an AIDS-defining disease in SpainAIDS, 1995
- Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patientsJAMA, 1979
- Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicityArchives of internal medicine (1960), 1977
- Isoniazid hepatitis in adolescentsThe Journal of Pediatrics, 1976
- Isoniazid toxicity. A prospective study in secondary chemoprophylaxis1972